Mitochondrial SANDO Syndrome

Mitochondrial SANDO Syndrome—short for Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis—is a very rare, adult-onset mitochondrial disorder. It belongs to the ataxia–neuropathy spectrum (ANS) of POLG-related diseases and is characterized by the triad of impaired coordination due to sensory nerve damage (ataxia), slurred speech (dysarthria), and weakness or paralysis of the eye muscles (ophthalmoparesis) rarediseases.orgen.wikipedia.org. Underlying the clinical picture is defective maintenance of mitochondrial DNA (mtDNA), often due to inherited mutations in the POLG gene, which encodes the DNA polymerase γ essential for replication of mtDNA medlineplus.gov. Symptoms progress slowly over years, and there is currently no cure—treatment focuses on managing symptoms and supporting quality of life.

Mitochondrial SANDO syndrome—short for Sensory Ataxic Neuropathy with Dysarthria and Ophthalmoplegia—is a rare, inherited mitochondrial disorder characterized by progressive sensory neuropathy (loss of sensation), ataxia (uncoordinated movement), slurred speech (dysarthria), and weakness of the eye muscles (ophthalmoplegia). It arises from mutations affecting mitochondrial DNA or nuclear genes that encode components of the oxidative phosphorylation (OXPHOS) system, leading to defective energy production in high-demand tissues such as nerves and muscles ncbi.nlm.nih.govnature.com. Onset typically occurs in adulthood, with gradual progression over years; common initial complaints include tingling (“pins and needles”), balance problems, and double vision medlineplus.gov.

---

Types of Mitochondrial SANDO Syndrome

Although SANDO itself is a single clinical phenotype, it can be classified into several subtypes based on genetic cause, age at onset, and presence of additional systemic features:

1. POLG-Related Classic SANDO
   Caused by autosomal-recessive mutations in POLG (most commonly p.A467T and p.W748S), this is the prototypical form. Onset typically occurs in the third or fourth decade, with progressive external ophthalmoplegia, ataxia, and sensory neuropathy. While vision and gait worsen gradually, life expectancy is only mildly reduced compared with more severe POLG disorders medlineplus.gov.

2. TWNK-Related SANDO
   In rarer cases, mutations in C10orf2 (also called TWNK or “Twinkle”) produce a clinically similar picture. TWNK mutations more often cause multiple mtDNA deletions rather than depletion, and patients sometimes show additional features such as hearing loss or gastrointestinal dysmotility de.wikipedia.org.

3. Juvenile-Onset SANDO
   A minority of patients experience first symptoms before age 20. Although genetically similar to the adult form, juvenile-onset SANDO can progress more rapidly, with earlier involvement of speech and swallowing, and a higher risk of seizures. Early recognition is crucial for supportive care.

4. Atypical Multisystem SANDO
   Some individuals develop the classic triad alongside other organ involvement—such as cardiomyopathy, liver dysfunction, or pancreatic insufficiency—reflecting a wider mitochondrial dysfunction. These cases often require multidisciplinary management.

5. Overlap Syndromes
   SANDO can overlap with other POLG-related phenotypes, such as Alpers–Huttenlocher syndrome or MIRAS (mitochondrial recessive ataxia syndrome). Patients in this overlap category may show more severe neurological deficits, including cognitive decline or refractory epilepsy.

---

Causes of Mitochondrial SANDO Syndrome

SANDO arises from a constellation of genetic and molecular mechanisms that compromise mitochondrial DNA maintenance, energy production, and nerve integrity. Key “causes” include:

1. POLG Gene Mutations
   The most common root cause, POLG mutations disrupt mtDNA replication, leading to mtDNA depletion or deletions in nerve and muscle cells medlineplus.gov.

2. TWNK (C10orf2) Mutations
   Twinkle helicase defects cause multiple mtDNA deletions, impairing energy metabolism in high-demand tissues such as nerves and extraocular muscles de.wikipedia.org.

3. MtDNA Depletion
   Excessive loss of mtDNA copies lowers the capacity for oxidative phosphorylation, starving cells of ATP.

4. Large-Scale MtDNA Deletions
   Deletions of critical regions of the mitochondrial genome compromise assembly of respiratory chain complexes.

5. Oxidative Phosphorylation Deficits
   Faulty complexes I or IV reduce ATP synthesis, particularly affecting neurons and muscle fibers.

6. Increased Reactive Oxygen Species
   Excess free radicals damage mitochondrial membranes and DNA, accelerating cell injury.

7. Impaired Mitochondrial Fusion–Fission Balance
   Disruption of dynamics leads to dysfunctional organelles that cannot meet cellular energy needs.

8. Mitophagy Defects
   Failure to clear damaged mitochondria results in accumulation of dysfunctional organelles.

9. Nuclear–Mitochondrial Signaling Breakdown
   Impaired cross-talk fails to adapt nuclear gene expression to mitochondrial stress.

10. Environmental Toxins
    Chemicals such as certain antibiotics or solvents can exacerbate mitochondrial dysfunction.

11. Alcohol Abuse
    Chronic alcohol intake increases oxidative stress and disrupts mitochondrial membranes.

12. Smoking
    Tobacco toxins generate free radicals that harm mtDNA integrity.

13. Nutritional Deficiencies
    Lack of cofactors (e.g., thiamine, riboflavin) can impair electron transport chain enzymes.

14. Metabolic Demands of Aging
    Aging neurons lose some capacity for mtDNA repair, unmasking latent defects.

15. Febrile Illnesses
    High metabolic stress during infection can precipitate symptom onset in susceptible individuals.

16. Physical Trauma
    Acute stress may trigger or worsen neuropathic symptoms in at-risk patients.

17. Chronic Inflammation
    Systemic inflammation can raise ROS levels, compounding mitochondrial damage.

18. Medication-Induced Toxicity
    Drugs like valproic acid can precipitate liver failure in POLG mutation carriers, indirectly affecting mitochondrial health.

19. Genetic Modifiers
    Variants in other nuclear genes can worsen or ameliorate mitochondrial maintenance.

20. Heteroplasmy Threshold Effects
    The proportion of mutated mtDNA must exceed a tissue-specific threshold before symptoms appear; shifts in heteroplasmy can trigger disease.

---

Symptoms of Mitochondrial SANDO Syndrome

Patients with SANDO experience a wide range of neurological and systemic symptoms. The twenty most common include:

1. Sensory Ataxia
   Damage to peripheral sensory nerves causes loss of position sense, leading to unsteady gait and falls rarediseases.org.

2. Dysarthria
   Weakness of speech muscles produces slow, slurred speech that worsens over time.

3. Ophthalmoparesis
   Impaired eye-muscle function leads to limited gaze, double vision, and eye-movement abnormalities.

4. Ptosis
   Drooping of the upper eyelids often appears early, reflecting diaphragmatic muscle weakness.

5. Peripheral Neuropathic Pain
   Patients may feel burning or shooting pains in the hands and feet.

6. Numbness and Tingling
   “Pins and needles” sensations reflect small-fiber sensory loss.

7. Limb Weakness
   Proximal or distal muscle weakness can affect daily activities.

8. Dysphagia
   Difficulty swallowing increases risk of aspiration and weight loss.

9. Hearing Loss
   Cochlear nerve involvement can lead to sensorineural deafness.

10. Fatigue
    Chronic energy deficiency causes profound tiredness, often worsening with exertion.

11. Exercise Intolerance
    Patients become breathless or weak after mild activity.

12. Myalgia
    Muscle aches reflect underlying mitochondrial myopathy.

13. Seizures
    Although less common, cortical involvement can trigger epilepsy.

14. Headaches and Migraines
    Vascular or metabolic stress in the brain may cause recurrent headaches.

15. Cardiac Conduction Defects
    Arrhythmias or heart-block can occur in multisystem variants.

16. Gastrointestinal Dysmotility
    Delayed gastric emptying and constipation arise from smooth‐muscle energy failure.

17. Depression and Cognitive Changes
    Mitochondrial dysfunction in the brain may lead to mood disorders.

18. Liver Dysfunction
    Elevated liver enzymes or steatosis may develop in severe cases.

19. Visual Field Defects
    Less common than ophthalmoparesis, but reflect optic nerve involvement.

20. Cognitive Fatigue (“Brain Fog”)
    Patients often report difficulty concentrating due to cerebral energy deficits.

---

Diagnostic Tests for Mitochondrial SANDO Syndrome

A thorough workup combines clinical examination, manual bedside tests, laboratory and pathological studies, electrodiagnostic evaluations, and imaging. Below are forty tests—eight in each category—each explained in simple English.

Physical Exam

1. General Neurological Examination
   A head-to-toe check of strength, reflexes, coordination, and sensation to identify patterns of nerve and muscle involvement.

2. Cranial Nerve Assessment
   Evaluation of eye movements, eyelid droop, facial strength, and speech helps pinpoint dysarthria and ophthalmoparesis.

3. Gait Observation
   Watching the patient walk—especially on heels, toes, and tandem—reveals sensory ataxia.

4. Romberg Test
   With eyes closed and feet together, swaying indicates loss of position sense in legs medlineplus.gov.

5. Reflex Testing
   Tapping tendons (knee, ankle) uncovers reduced or absent deep-tendon reflexes in neuropathy.

6. Sensory Mapping
   Light touch, pinprick, and vibration tests over arms and legs define the extent of sensory loss.

7. Speech and Swallowing Evaluation
   Asking the patient to read passages or swallow liquids assesses the severity of dysarthria and dysphagia.

8. Postural Stability Check
   Gently nudging the shoulders tests ability to maintain balance, reflecting cerebellar versus sensory ataxia.

Manual Tests

1. Tuning-Fork Vibration Test
   Placing a 128-Hz fork on bony prominences measures vibration sense in feet and ankles.

2. Monofilament Sensory Test
   A nylon filament checks light-touch thresholds on the soles, detecting small-fiber neuropathy.

3. Pinprick Discrimination Test
   A sterile pin lightly pricks the skin to gauge sharp versus dull sensation.

4. Joint-Position Sense Test
   Moving toes or fingers up/down with eyes closed tests proprioception directly.

5. Heel-Shin Slide
   The patient slides one heel down the opposite shin; deviation indicates cerebellar or sensory ataxia.

6. Finger-Nose-Finger Test
   Touching nose then examiner’s finger repeatedly uncovers dysmetria from ataxia.

7. Rapid Alternating Movements
   Quickly flipping the palms up and down detects dysdiadochokinesia in cerebellar involvement.

8. Fukuda Stepping Test
   Marching in place with eyes closed; rotation or drift suggests vestibular or sensory pathway lesions.

Laboratory and Pathological Tests

1. Serum Lactate and Pyruvate Levels
   Elevated resting or exercise-induced ratios indicate mitochondrial respiration defects.

2. Creatine Kinase (CK) Activity
   Mild to moderate CK elevation reflects mitochondrial myopathy.

3. Amino Acid and Organic Acid Profiling
   Specialized blood and urine tests reveal metabolic byproducts of faulty oxidative phosphorylation.

4. Muscle Biopsy Histology
   Light microscopy may show “ragged-red fibers,” a hallmark of mitochondrial myopathies.

5. Electron Microscopy
   Ultra-structural analysis of muscle samples uncovers abnormal, enlarged mitochondria.

6. MtDNA Copy-Number Quantification
   PCR-based assays measure mtDNA depletion in muscle or nerve tissue.

7. Large-Scale MtDNA Deletion Screening
   Southern blot or long-range PCR can detect common deletion patterns.

8. Respiratory Chain Enzyme Assays
   Spectrophotometric measurement of complexes I–IV activities confirms OXPHOS deficits.

Electrodiagnostic Tests

1. Nerve Conduction Studies (NCS)
   Electrical stimulation of peripheral nerves quantifies sensory conduction velocity and amplitude, diagnosing sensory neuropathy.

2. Electromyography (EMG)
   Needle electrodes in muscle detect spontaneous activity and motor unit changes of myopathy.

3. Somatosensory Evoked Potentials (SSEPs)
   Recording cortical responses to peripheral nerve stimulation assesses dorsal column pathways.

4. Electroencephalography (EEG)
   Monitoring brain waves uncovers subclinical seizure activity or encephalopathy.

5. Blink Reflex Test
   Electrical stimulation of the supraorbital nerve evaluates trigeminal and facial nerve circuits, useful in cranial neuropathy.

6. Repetitive Nerve Stimulation
   Helps rule out neuromuscular junction disorders in patients presenting with ophthalmoparesis.

7. Quantitative Sensory Testing (QST)
   Psychophysical techniques measure thresholds for vibration, cold, and heat, mapping small-fiber involvement.

8. Autonomic Function Tests
   Heart-rate variability, tilt-table testing, and sweat tests assess autonomic nerve involvement in systemic variants.

Imaging Tests

1. Brain MRI
   T2-weighted and FLAIR sequences may show cerebellar atrophy or thalamic lesions en.wikipedia.org.

2. Magnetic Resonance Spectroscopy (MRS)
   Detects elevated lactate peaks in white matter, supportive of mitochondrial dysfunction.

3. Muscle MRI
   Patterns of fatty infiltration and edema highlight involved muscle groups in mitochondrial myopathy.

4. Cardiac MRI
   Evaluates myocardial involvement in multisystem SANDO, including fibrosis or cardiomyopathy.

5. CT Scan
   Useful for rapid assessment of brain or chest when MRI is contraindicated.

6. 31P-MRS
   Phosphorus spectroscopy in muscle quantifies high-energy phosphate metabolites in vivo.

7. Ophthalmic Ultrasound
   Assesses extraocular muscle thickness and excludes other causes of ophthalmoparesis.

8. Gastrointestinal Transit Studies
   Scintigraphy evaluates gastric emptying when dysmotility is suspected.

Non-Pharmacological Treatments

Physiotherapy and Electrotherapy Therapies

1. Balance Training Exercises

   • Description: Targeted tasks (e.g., standing on foam, tandem walking) to improve proprioception.

   • Purpose: Enhance joint position sense and reduce fall risk.

   • Mechanism: Stimulates sensory feedback loops and cerebellar adaptation newcastle-mitochondria.com.

2. Gait Re-education

   • Description: Treadmill or overground walking with therapist guidance.

   • Purpose: Normalize stride length and cadence.

   • Mechanism: Repetitive, task-specific practice reinforces central motor programs newcastle-mitochondria.com.

3. Neuromuscular Electrical Stimulation (NMES)

   • Description: Low-frequency electrical pulses to peripheral nerves.

   • Purpose: Preserve muscle bulk and improve motor unit recruitment.

   • Mechanism: Direct activation of motor axons promotes muscle contraction and prevents atrophy en.wikipedia.org.

4. Transcutaneous Electrical Nerve Stimulation (TENS)

   • Description: Surface electrodes deliver high-frequency currents.

   • Purpose: Alleviate neuropathic pain.

   • Mechanism: “Gate control” inhibition of pain transmission in dorsal horn en.wikipedia.org.

5. Side-Altering Vibration Training

   • Description: Standing on a platform that oscillates laterally.

   • Purpose: Enhance trunk stability and proprioceptive sensitivity.

   • Mechanism: Rapid perturbations engage automatic postural responses and muscle spindles pmc.ncbi.nlm.nih.gov.

6. Cryotherapy

   • Description: Cold pack application to limbs.

   • Purpose: Reduce pain and inflammation.

   • Mechanism: Lowers nerve conduction velocity and metabolism at site en.wikipedia.org.

7. Heat Therapy

   • Description: Warm baths or heating pads.

   • Purpose: Soften stiff tissues and ease discomfort.

   • Mechanism: Increases local blood flow and tissue elasticity en.wikipedia.org.

8. Ultrasound Therapy

   • Description: High-frequency sound waves applied via a probe.

   • Purpose: Promote tissue healing and reduce pain.

   • Mechanism: Mechanical micro-vibrations stimulate cell activity and blood flow en.wikipedia.org.

9. Diagonal Pattern Training (PNF)

   • Description: Proprioceptive Neuromuscular Facilitation stretching patterns.

   • Purpose: Improve coordination and flexibility.

   • Mechanism: Uses spiral and diagonal limb motions to engage multiple muscle groups newcastle-mitochondria.com.

10. Joint Mobilization

    • Description: Manual therapy to improve joint play.

    • Purpose: Enhance range of motion.

    • Mechanism: Gentle oscillatory forces reduce capsular stiffness newcastle-mitochondria.com.

11. Functional Electrical Stimulation (FES) Cycling

    • Description: Combining electrical stimulation with leg cycling.

    • Purpose: Cardiovascular conditioning and muscle strength.

    • Mechanism: Synchronizes muscle contraction to pedaling, increasing aerobic capacity en.wikipedia.org.

12. Proprioceptive Training with Balance Boards

    • Description: Exercises on wobble or rocker boards.

    • Purpose: Improve ankle stability and sensory feedback.

    • Mechanism: Challenges postural control, enhancing afferent signaling newcastle-mitochondria.com.

13. Mirror Therapy

    • Description: Using mirror visual feedback to “replace” impaired limb.

    • Purpose: Reduce pain and improve movement.

    • Mechanism: Visual input modulates cortical representations and pain pathways newcastle-mitochondria.com.

14. Hydrotherapy

    • Description: Exercises in warm water pools.

    • Purpose: Reduce weight-bearing, facilitate movement.

    • Mechanism: Buoyancy decreases joint load, warmth relaxes muscles newcastle-mitochondria.com.

15. Functional Task Practice

    • Description: Activities of daily living (e.g., buttoning, cooking) under supervision.

    • Purpose: Maintain independence and fine motor skills.

    • Mechanism: Repetitive, goal-oriented tasks reinforce neuroplastic changes now.aapmr.org.

Exercise Therapies

1. Aerobic Endurance Training
   Gradual walking or cycling to improve cardiovascular fitness and mitochondrial capacity ebsco.com.

2. Resistance Training
   Low-load, high-repetition weight exercises to strengthen proximal muscles and counteract atrophy ebsco.com.

3. Interval Training
   Short bursts of activity (e.g., 1 min fast walking) alternated with rest to maximize mitochondrial biogenesis ebsco.com.

4. Task-Specific Muscle Re-Education
   Repeated practice of precision tasks (e.g., picking up small objects) to enhance fine motor control now.aapmr.org.

5. Stretching Programs
   Daily gentle stretches to maintain joint mobility and prevent contractures now.aapmr.org.

Mind–Body Interventions

1. Yoga
   Combines postures, breathing, and meditation; reduces stress and may improve mitochondrial function en.wikipedia.org.

2. Tai Chi
   Gentle martial art focusing on slow movements; enhances balance and proprioception en.wikipedia.org.

3. Basic Body Awareness Therapy (B-BAT)
   Holistic movement therapy improving body awareness and reducing tension en.wikipedia.org.

4. Guided Imagery
   Relaxation technique to reduce pain perception and anxiety en.wikipedia.org.

5. Mindfulness Meditation
   Focused attention practice to modulate pain and emotional stress en.wikipedia.org.

Educational Self-Management Programs

1. Energy Conservation Techniques
   Training on pacing activities and rest breaks to manage fatigue now.aapmr.org.

2. Symptom Tracking and Journaling
   Patients record triggers and symptom patterns to inform care now.aapmr.org.

3. Nutritional Counseling
   Guidance on balanced diet, avoidance of fasting, and meal timing to support mitochondrial health now.aapmr.org.

4. Medication Review Workshops
   Education on drugs to avoid (e.g., valproate, aminoglycosides) that can worsen mitochondrial function now.aapmr.org.

5. Falls Prevention Education
   Home safety assessments and strategies (e.g., remove rugs, install grab bars) to reduce injury risk now.aapmr.org.

---

Evidence-Based Pharmacological Treatments

Each of the following agents is used to support mitochondrial function or manage symptoms.

1. Coenzyme Q10 (Ubiquinone)

   • Class: Antioxidant, electron transport chain cofactor

   • Dosage: 100–400 mg/day, divided doses

   • Timing: With meals for absorption

   • Side Effects: GI upset, insomnia at high doses pmc.ncbi.nlm.nih.govmitoaction.org.

2. Idebenone

   • Class: Short-chain coenzyme Q analog

   • Dosage: 225–540 mg/day

   • Timing: TID with meals

   • Side Effects: Diarrhea, nausea pmc.ncbi.nlm.nih.gov.

3. Riboflavin (Vitamin B2)

   • Class: B-vitamin cofactor

   • Dosage: 200–400 mg/day

   • Timing: Once or twice daily

   • Side Effects: Rare; urine may turn bright yellow pmc.ncbi.nlm.nih.gov.

4. Thiamine (Vitamin B1)

   • Class: B-vitamin cofactor

   • Dosage: 100–300 mg/day

   • Timing: BID

   • Side Effects: Rare; possible allergic reaction en.wikipedia.org.

5. Niacin (Vitamin B3)

   • Class: NAD+ precursor

   • Dosage: 500 mg/day

   • Timing: With food to reduce flushing

   • Side Effects: Flushing, GI upset nature.com.

6. Pyridoxine (Vitamin B6)

   • Class: B-vitamin cofactor

   • Dosage: 50–100 mg/day

   • Timing: Once daily

   • Side Effects: Rare neuropathy at very high doses nature.com.

7. Folic Acid

   • Class: B-vitamin

   • Dosage: 1 mg/day

   • Timing: Once daily

   • Side Effects: Rare GI upset nature.com.

8. Biotin (Vitamin B7)

   • Class: B-vitamin

   • Dosage: 5 mg/day

   • Timing: Once daily

   • Side Effects: Rare; may interfere with labs nature.com.

9. Vitamin C (Ascorbic Acid)

   • Class: Antioxidant

   • Dosage: 500–1,000 mg/day

   • Timing: BID

   • Side Effects: GI upset, diarrhea en.wikipedia.org.

10. Vitamin E (Tocopherol)

    • Class: Lipid-soluble antioxidant

    • Dosage: 400–800 IU/day

    • Timing: With fat-containing meal

    • Side Effects: Bleeding risk at high doses chop.edu.

11. Alpha-Lipoic Acid

    • Class: Antioxidant, cofactor

    • Dosage: 300–600 mg/day

    • Timing: BID

    • Side Effects: Skin rash, GI upset ebsco.com.

12. N-Acetylcysteine (NAC)

    • Class: Antioxidant precursor

    • Dosage: 600–1,200 mg/day

    • Timing: BID

    • Side Effects: Nausea, vomiting nmi.health.

13. Creatine Monohydrate

    • Class: Energy precursor

    • Dosage: 5 g BID

    • Timing: With meals

    • Side Effects: Weight gain, GI upset pmc.ncbi.nlm.nih.govhealthrising.org.

14. L-Carnitine

    • Class: Fatty acid transporter

    • Dosage: 2 g/day

    • Timing: BID

    • Side Effects: Fishy odor, diarrhea en.wikipedia.org.

15. Acetyl-L-Carnitine

    • Class: Mitochondrial antioxidant

    • Dosage: 1–3 g/day

    • Timing: BID

    • Side Effects: GI upset, agitation nature.com.

16. Dichloroacetate (DCA)

    • Class: PDH activator

    • Dosage: 12.5 mg/kg/day divided

    • Timing: BID

    • Side Effects: Peripheral neuropathy, GI upset en.wikipedia.org.

17. Sodium Pyruvate

    • Class: Energy substrate

    • Dosage: 0.1–0.3 g/kg/day

    • Timing: TID

    • Side Effects: Electrolyte imbalance en.wikipedia.org.

18. EPI-743 (Vatiquinone)

    • Class: Antioxidant redox modulator

    • Dosage: 15 mg/kg TID (max 200 mg/dose)

    • Timing: TID with meals

    • Side Effects: Headache, GI upset clinicaltrials.gov.

19. MitoQ (Mitoquinone)

    • Class: Mitochondria-targeted antioxidant

    • Dosage: 10–20 mg/day

    • Timing: Once daily

    • Side Effects: Rare GI upset nature.com.

20. Resveratrol

    • Class: SIRT1 activator, antioxidant

    • Dosage: 500 mg/day

    • Timing: With meals

    • Side Effects: GI upset, headache nature.com.

---

Dietary Molecular Supplements

1. Citrulline Malate

   • Dosage: 6 g/day in divided doses

   • Function: Enhances urea cycle, reduces ammonia

   • Mechanism: Increases nitric oxide and ATP production mitocanada.org.

2. L-Arginine

   • Dosage: 0.1 g/kg/day

   • Function: Ammonia detoxification, vasodilation

   • Mechanism: Precursor for nitric oxide synthesis mitocanada.org.

3. Taurine

   • Dosage: 1.5 g/day

   • Function: Osmoregulation, antioxidant

   • Mechanism: Stabilizes calcium handling in mitochondria nature.com.

4. Nicotinamide Riboside

   • Dosage: 500 mg/day

   • Function: NAD+ precursor

   • Mechanism: Supports OXPHOS and DNA repair nature.com.

5. Pyrroloquinoline Quinone (PQQ)

   • Dosage: 20 mg/day

   • Function: Mitochondrial biogenesis

   • Mechanism: Activates PGC-1α pathway nature.com.

6. Resveratrol

   • Dosage: 500 mg/day

   • Function: Anti-inflammatory, antioxidant

   • Mechanism: SIRT1 activation promoting mitochondrial health nature.com.

7. Magnesium

   • Dosage: 300 mg/day

   • Function: ATP cofactor

   • Mechanism: Stabilizes ATP-dependent enzymes nature.com.

8. Omega-3 Fatty Acids (EPA/DHA)

   • Dosage: 2 g/day

   • Function: Anti-inflammatory

   • Mechanism: Modulates membrane fluidity and signaling nature.com.

9. Curcumin

   • Dosage: 500 mg BID

   • Function: Antioxidant, anti-inflammatory

   • Mechanism: NF-κB inhibition, ROS scavenging nature.com.

10. Sapropterin (BH4)

    • Dosage: 10 mg/kg/day

    • Function: NOS cofactor, neurotransmitter synthesis

    • Mechanism: Enhances nitric oxide production and antioxidant defenses nature.com.

---

Advanced Therapeutic Drugs

1. Alendronate (Bisphosphonate)

   • Dosage: 70 mg weekly or 10 mg daily

   • Function: Inhibits osteoclast-mediated bone resorption

   • Mechanism: Binds hydroxyapatite, induces osteoclast apoptosis mayoclinic.org.

2. Risedronate (Bisphosphonate)

   • Dosage: 35 mg weekly or 5 mg daily

   • Function: Similar to alendronate

   • Mechanism: Inhibits farnesyl diphosphate synthase in osteoclasts osteoporosis.ca.

3. Zoledronic Acid (Bisphosphonate)

   • Dosage: 5 mg IV annually

   • Function: Potent osteoclast inhibitor

   • Mechanism: Disrupts osteoclast cytoskeleton osteoporosis.ca.

4. Hyaluronic Acid (Viscosupplement)

   • Dosage: 16 mg (2 mL) weekly × 3 weeks

   • Function: Restores joint lubrication

   • Mechanism: Acts as shock absorber in synovial fluid reference.medscape.com.

5. Synvisc (Hylan G-F 20)

   • Dosage: 16 mg weekly × 3 weeks or 48 mg single injection

   • Function: Enhanced viscosupplementation

   • Mechanism: High-molecular-weight hyaluronan reference.medscape.com.

6. Orthovisc

   • Dosage: 30 mg (2 mL) weekly × 3 weeks

   • Function: Delayed-release hyaluronan

   • Mechanism: Longer half-life in joint reference.medscape.com.

7. Platelet-Rich Plasma (PRP)

   • Dosage: ≥10 billion platelets per 8 mL injection

   • Function: Regenerative biologic

   • Mechanism: Releases growth factors (PDGF, TGF-β, VEGF) to stimulate tissue repair nature.com.

8. Remestemcel-L (Ryoncil)

   • Dosage: 1–2×10⁶ MSCs/kg IV

   • Function: Immunomodulation, mitochondrial transfer

   • Mechanism: MSCs donate healthy mitochondria and secrete trophic factors en.wikipedia.org.

9. Sonlicromanol (KH176)

   • Dosage: 100 mg BID

   • Function: Redox modulator, antioxidant

   • Mechanism: Inhibits mPGES-1 and augments thioredoxin/peroxiredoxin activity en.wikipedia.org.

10. EPI-743 (Vatiquinone)

    • Dosage: 15 mg/kg TID (max 200 mg/dose)

    • Function: Redox-modulating antioxidant

    • Mechanism: Enhances glutathione synthesis and mitigates ferroptosis clinicaltrials.gov.

---

Surgical Procedures

1. Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement

   • Procedure: Endoscopic insertion of feeding tube into stomach

   • Benefits: Long-term enteral nutrition, reduced aspiration risk en.wikipedia.org.

2. Upper Eyelid Blepharoplasty/Ptosis Repair

   • Procedure: Excision of excess eyelid skin and tightening of levator muscle

   • Benefits: Improved vision field, reduced eyelid heaviness en.wikipedia.org.

3. Strabismus Surgery

   • Procedure: Recession or resection of extraocular muscles

   • Benefits: Aligns eyes, reduces diplopia.

4. Posterior Tibial Tendon Transfer

   • Procedure: Transfers tendon to dorsiflexor to correct foot drop

   • Benefits: Restores heel-to-toe gait.

5. Tarsal Tunnel Release (Peripheral Nerve Decompression)

   • Procedure: Decompression of posterior tibial nerve at ankle

   • Benefits: Reduces neuropathic foot pain.

6. Spinal Fusion for Scoliosis

   • Procedure: Posterior instrumentation and arthrodesis

   • Benefits: Stabilizes curvature, reduces pain.

7. Achilles Tendon Lengthening

   • Procedure: Surgical release of tendon

   • Benefits: Improves ankle dorsiflexion, gait.

8. Cataract Extraction

   • Procedure: Phacoemulsification with lens implant

   • Benefits: Restores lens clarity, improves visual acuity.

9. Cochlear Implant

   • Procedure: Electrode array insertion in cochlea

   • Benefits: Improves sensorineural hearing loss.

10. Deep Brain Stimulation (DBS)

    • Procedure: Implantation of electrodes in thalamus or globus pallidus

    • Benefits: Reduces myoclonus and movement disorders.

---

Prevention Strategies

1. Avoid Mitochondrial Toxins

   • Refrain from valproate, aminoglycosides, and certain anesthetics now.aapmr.org.

2. Regular Moderate Exercise

   • Maintains mitochondrial density without causing overexertion ebsco.com.

3. Balanced Diet with Adequate Cofactors

   • Ensures supply of vitamins and antioxidants en.wikipedia.org.

4. Avoid Fasting or Prolonged Starvation

   • Prevents catabolic stress on mitochondria now.aapmr.org.

5. Stay Hydrated

   • Supports cellular metabolism.

6. Temperature Regulation

   • Avoid extreme heat or cold to reduce metabolic demand.

7. Vaccinations

   • Prevents infections that can trigger metabolic crises now.aapmr.org.

8. Genetic Counseling

   • Informs family planning and surveillance.

9. Stress Management

   • Reduces oxidative stress through relaxation techniques en.wikipedia.org.

10. Regular Neuromuscular Assessments

    • Early detection of progression to adjust management nature.com.

---

When to See a Doctor

Seek prompt evaluation if you experience:

• New or worsening sensory loss or numbness

• Sudden balance problems or falls

• Acute vision changes (double vision)

• Progressive difficulty swallowing or speaking

• New-onset seizure or tremor

• Significant weight loss or malnutrition

• Severe, unrelenting pain

• Breathing difficulty or sleep apnea

• Cardiac symptoms (palpitations, syncope)

• Rapid functional decline in activities of daily living nature.com.

---

What to Do and What to Avoid

Do:

1. Maintain regular follow-up with neurology and rehabilitation specialists.

2. Adhere to prescribed “mitochondrial cocktail” supplements.

3. Practice energy conservation and paced activities.

4. Engage in tailored physiotherapy and exercise programs.

5. Eat small, frequent meals rich in cofactors.

6. Record symptoms and triggers in a diary.

7. Ensure good sleep hygiene.

8. Stay up to date with vaccinations.

9. Monitor bone health (DEXA scans).

10. Seek support from patient groups and counselors.

Avoid:

1. High-dose steroids and valproate without specialist oversight.

2. Extreme-temperature exposures (hot baths, cold immersion).

3. Prolonged fasting or crash diets.

4. Smoking and excessive alcohol.

5. Overexertion beyond prescribed limits.

6. Unsupervised use of over-the-counter stimulants.

7. Exposure to environmental toxins (pesticides, heavy metals).

8. Skipping meals or supplements.

9. Neglecting dental care (risk of bisphosphonate osteonecrosis).

10. High-intensity contact sports (fall risk).

---

Frequently Asked Questions (FAQs)

1. What causes SANDO syndrome?
   Mutations in mitochondrial or nuclear genes impair OXPHOS, leading to energy failure in nerves and muscles.

2. Is SANDO syndrome inherited?
   Yes—patterns include maternal (mtDNA) or autosomal recessive (nuclear DNA).

3. Can SANDO be cured?
   Currently, no cure exists; management focuses on supportive therapies and slowing progression.

4. How is SANDO diagnosed?
   Through clinical evaluation, nerve conduction studies, muscle biopsy, and genetic testing.

5. What is the life expectancy?
   Varies by mutation; many live decades with supportive care.

6. Are there specific diets recommended?
   A balanced diet with frequent meals and mitochondrial cofactors is advised.

7. Can exercise help?
   Yes—moderate, tailored exercise enhances mitochondrial capacity without undue stress.

8. Which medications should be avoided?
   Valproate, aminoglycosides, and certain anesthetics that impair mitochondrial function.

9. Are there specialized exercise programs?
   Yes—programs include aerobic, resistance, and balance training under physiotherapist guidance.

10. What role do supplements play?
    Cofactor “cocktails” (CoQ10, riboflavin, etc.) aim to support residual mitochondrial function.

11. Can genetic counseling help?
    Absolutely—for family planning and understanding inheritance risks.

12. When should I consider a feeding tube?
    When dysphagia leads to malnutrition or risk of aspiration.

13. Is physical therapy necessary?
    Yes—prevents contractures, maintains strength, and enhances safety.

14. How do I manage fatigue?
    Through energy conservation techniques, paced activities, and adequate rest.

15. Where can I find support?
    Patient advocacy groups (e.g., United Mitochondrial Disease Foundation) and specialized clinics provide resources.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 07, 2025.